| Chandra Mathis, FNP-C | |
|
1200 Fort St, Barling, AR 72923 | |
| (479) 763-1511 | |
| (479) 763-1545 |
| Full Name | Chandra Mathis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1200 Fort St, Barling, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548718125 | NPI | - | NPPES |
| 221472758 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP2300X | Nurse Practitioner - Primary Care | A004908 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Fort Smith | Fort smith, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urgent Team Of Arkansas Physicians Llc | 1850539198 | 114 |
| Mercy Clinic Fort Smith Communities | 3870668510 | 273 |
News Archive
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
During an event with leaders from three U.S. federal agencies and the White House, the executive director of the Merck Childhood Asthma Network, Inc. (MCAN), Dr. Floyd Malveaux, expressed strong support for the government's new coordinated action plan to reduce racial and ethnic asthma disparities. The release of the new report came on the last day of National Asthma Awareness Month.
In its first decade, the GAVI Alliance has helped prevent the deaths of more than five million children by introducing more widespread vaccination in low-income countries, "[b]ut, going forward, the alliance is going to have to think more about getting parents to vaccinate their kids - the demand side of health - especially if it wants to repeat the huge victory of wiping out a disease" such as smallpox, Charles Kenny writes in his weekly column for Foreign Policy.
CardioNet, Inc. announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 ("Biological Signal Management") to CardioNet. The patent includes certain systems and techniques utilized by the Company's Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex physiological information to make it useful for clinical decisions.
› Verified 8 days ago
| Entity Name | Mercy Clinic Fort Smith Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902073620 PECOS PAC ID: 3870668510 Enrollment ID: O20080814000789 |
News Archive
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
During an event with leaders from three U.S. federal agencies and the White House, the executive director of the Merck Childhood Asthma Network, Inc. (MCAN), Dr. Floyd Malveaux, expressed strong support for the government's new coordinated action plan to reduce racial and ethnic asthma disparities. The release of the new report came on the last day of National Asthma Awareness Month.
In its first decade, the GAVI Alliance has helped prevent the deaths of more than five million children by introducing more widespread vaccination in low-income countries, "[b]ut, going forward, the alliance is going to have to think more about getting parents to vaccinate their kids - the demand side of health - especially if it wants to repeat the huge victory of wiping out a disease" such as smallpox, Charles Kenny writes in his weekly column for Foreign Policy.
CardioNet, Inc. announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 ("Biological Signal Management") to CardioNet. The patent includes certain systems and techniques utilized by the Company's Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex physiological information to make it useful for clinical decisions.
› Verified 8 days ago
| Entity Name | Urgent Team Of Arkansas Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992041370 PECOS PAC ID: 1850539198 Enrollment ID: O20130529000209 |
News Archive
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
During an event with leaders from three U.S. federal agencies and the White House, the executive director of the Merck Childhood Asthma Network, Inc. (MCAN), Dr. Floyd Malveaux, expressed strong support for the government's new coordinated action plan to reduce racial and ethnic asthma disparities. The release of the new report came on the last day of National Asthma Awareness Month.
In its first decade, the GAVI Alliance has helped prevent the deaths of more than five million children by introducing more widespread vaccination in low-income countries, "[b]ut, going forward, the alliance is going to have to think more about getting parents to vaccinate their kids - the demand side of health - especially if it wants to repeat the huge victory of wiping out a disease" such as smallpox, Charles Kenny writes in his weekly column for Foreign Policy.
CardioNet, Inc. announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 ("Biological Signal Management") to CardioNet. The patent includes certain systems and techniques utilized by the Company's Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex physiological information to make it useful for clinical decisions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chandra Mathis, FNP-C 1200 Fort St Ste A, Barling, AR 72923-2013 Ph: (479) 763-1511 | Chandra Mathis, FNP-C 1200 Fort St, Barling, AR 72923 Ph: (479) 763-1511 |
News Archive
Celtaxsys, Inc., a clinical stage pharmaceutical development company focusing on anti-inflammatory therapeutics, including those with rare and orphan inflammatory disease indications, announced today that it has gained clearance from the U.S. Food and Drug Administration to begin a Phase 2 clinical trial of its flagship drug candidate, acebilustat (CTX-4430), in adult CF patients in the US.
During an event with leaders from three U.S. federal agencies and the White House, the executive director of the Merck Childhood Asthma Network, Inc. (MCAN), Dr. Floyd Malveaux, expressed strong support for the government's new coordinated action plan to reduce racial and ethnic asthma disparities. The release of the new report came on the last day of National Asthma Awareness Month.
In its first decade, the GAVI Alliance has helped prevent the deaths of more than five million children by introducing more widespread vaccination in low-income countries, "[b]ut, going forward, the alliance is going to have to think more about getting parents to vaccinate their kids - the demand side of health - especially if it wants to repeat the huge victory of wiping out a disease" such as smallpox, Charles Kenny writes in his weekly column for Foreign Policy.
CardioNet, Inc. announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 ("Biological Signal Management") to CardioNet. The patent includes certain systems and techniques utilized by the Company's Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex physiological information to make it useful for clinical decisions.
› Verified 8 days ago
Tina Marie Gragg, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10301 Mayo Dr, Barling, AR 72923 Phone: 479-494-5700 | |
Brittney Lynn Sims, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1311 Fort St Ste F, Barling, AR 72923 Phone: 816-769-1680 | |
Ashley Nicole Herren, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10301 Mayo Dr, Barling, AR 72923 Phone: 479-494-5700 | |
Tammy Rodgers, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10301 Mayo Dr, Barling, AR 72923 Phone: 479-494-5700 Fax: 479-494-5777 | |
Kimberlee Sartain, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 815 Fort St Ste A, Barling, AR 72923 Phone: 479-235-5597 | |
Heather Rae Butler, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7003 Chad Colley Blvd, Barling, AR 72923 Phone: 479-431-3500 Fax: 479-452-2098 |